Doudna Honored with the Japan Prize

"Jennifer Doudna and Emmanuelle Charpentier were awarded the Japan Prize today for their invention of the revolutionary gene-editing technology known as CRISPR-Cas9, which has swept into research labs around the world and is already yielding new therapies for cancer and hereditary diseases."


Emmanuelle Charpentier and Jennifer Doudna after the announcement in Tokyo that they received the 2017 Japan Prize. Courtesy of the Japan Prize Foundation.